The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis.

Lone cryptogenic fibrosing alveolitis (CFA) is a progressive interstitial lung disease, with a median survival of 3 to 6 yr from the onset of dyspnea. CFA can be subdivided into prognostically significant histopathologic patterns, including nonspecific interstitial pneumonia (NSIP). We reviewed 78 patients with a clinicopathologic diagnosis of CFA, biopsied between 1978 and 1989, to evaluate the prevalence and prognostic significance of these histopathologic patterns, in particular NSIP. Biopsy appearances were reclassified by two pulmonary histopathologists as usual interstitial pneumonia (UIP) (47%), NSIP (36%), or desquamative interstitial pneumonia (DIP)/respiratory bronchiolitis-associated interstitial lung disease (RBILD) (17%). The kappa coefficient of agreement between pathologists was 0.49. In 67 cases, follow-up was complete to death or 10 yr after biopsy, with 50 deaths during a median follow-up of 42 mo (UIP, 89%; NSIP, 61%, DIP/RBILD, 0%). Survival was highest in DIP/RBILD and higher in NSIP than UIP, p < 0.0005. When analysis was confined to patients with UIP or NSIP, the mortality of UIP remained higher, p < 0.01, but the 5-yr survival in patients with fibrotic NSIP was only 45%, indicating that this histologic appearance is often associated with a poor outcome. A response to treatment was more frequent in DIP/RBILD than in NSIP (p < 0.01) or UIP (p < 0.0005). This study confirms the prognostic value of subclassifying patients with CFA according to histopathologic pattern. However, in patients with clinically typical CFA, a histologic diagnosis of fibrotic NSIP needs to be interpreted with caution and does not necessarily denote a good outcome.

[1]  J. Myers,et al.  Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. , 2000, The American journal of surgical pathology.

[2]  W. Travis,et al.  Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. , 2000, The American journal of surgical pathology.

[3]  A. Nicholson,et al.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. , 1999, American journal of respiratory and critical care medicine.

[4]  T. Colby,et al.  Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. , 1998, The European respiratory journal.

[5]  J. Myers,et al.  Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. , 1998, American journal of respiratory and critical care medicine.

[6]  R. Hubbard,et al.  Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study. , 1998, Chest.

[7]  K P Offord,et al.  Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. , 1998, American journal of respiratory and critical care medicine.

[8]  M. Akira,et al.  Serial computed tomographic evaluation in desquamative interstitial pneumonia. , 1997, Thorax.

[9]  I. D. Johnston,et al.  British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society. , 1997, Thorax.

[10]  A. Nicholson,et al.  Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. , 1996, Clinical radiology.

[11]  N. Müller,et al.  Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia. Assessment with serial CT. , 1996, Chest.

[12]  R. Wu,et al.  Changes in pulmonary function test results after 1 year of therapy as predictors of survival in patients with idiopathic pulmonary fibrosis. , 1995, Chest.

[13]  D. Hansell,et al.  Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. , 1994, American journal of respiratory and critical care medicine.

[14]  C D Collins,et al.  Observer variation in pattern type and extent of disease in fibrosing alveolitis on thin section computed tomography and chest radiography. , 1994, Clinical radiology.

[15]  A. Katzenstein,et al.  Nonspecific Interstitial Pneumonia/Fibrosis: Histologic Features and Clinical Significance , 1994, The American journal of surgical pathology.

[16]  D M Hansell,et al.  Serial CT in fibrosing alveolitis: prognostic significance of the initial pattern. , 1993, AJR. American journal of roentgenology.

[17]  P. Bardin,et al.  Cyclosporin as a treatment for interstitial lung disease of unknown aetiology. , 1991, Thorax.

[18]  M. Kitaichi Pathologic features and the classification of interstitial pneumonia of unknown etiology. , 1990, Bulletin of the Chest Disease Research Institute, Kyoto University.

[19]  T. Chinet,et al.  Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA. , 1990, The American review of respiratory disease.

[20]  T. Colby,et al.  Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. , 1989, Mayo Clinic proceedings.

[21]  J. Darbyshire,et al.  Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. , 1989, Thorax.

[22]  F. Ognibene,et al.  Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV). , 1988, Annals of internal medicine.

[23]  G. Raghu Idiopathic pulmonary fibrosis. A rational clinical approach. , 1987, Chest.

[24]  J. Myers,et al.  Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. , 1987, The American review of respiratory disease.

[25]  J. Myers,et al.  Acute Interstitial Pneumonia: A Clinicopathologic, Ultrastmctural, and Cell Kinetic Study , 1986, The American journal of surgical pathology.

[26]  R. Crystal,et al.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. , 1984, The New England journal of medicine.

[27]  E. Taskinen,et al.  Prognosis of cryptogenic fibrosing alveolitis. , 1983, Thorax.

[28]  V. Ferrans,et al.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.

[29]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival , 1980, Thorax.

[30]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[31]  R G Gupta,et al.  Natural history and treated course of usual and desquamative interstitial pneumonia. , 1978, The New England journal of medicine.

[32]  A. Fishman UIP, DIP, and all that. , 1978, The New England journal of medicine.

[33]  B. Heard,et al.  The prognosis of cryptogenic fibrosing alveolitis , 1972, British medical journal.

[34]  W. Roberts,et al.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.

[35]  J. Scadding,et al.  Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs) , 1967, Thorax.

[36]  L. Woolner,et al.  Pulmonary fibrosis. , 1954, The Medical clinics of North America.